Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis - PubMed (original) (raw)
. 1997 May 1;57(9):1634-7.
Affiliations
- PMID: 9134998
Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis
S Gansauge et al. Cancer Res. 1997.
Abstract
We have investigated the expression of cyclin D1 in adenocarcinoma of the pancreas and the relevance of cyclin D1 expression to clinical outcome. In comparison to normal pancreas, Southern blot analyses revealed amplification of the cyclin D1 coding gene in 25% of the cases, whereas with reverse transcription-PCR, overexpression of mRNA was observed in 82% of the examined tissues. Immunohistochemically, we could demonstrate nuclear overexpression in tumor cells in 68.4%, and this protein accumulation correlated significantly with poor prognosis [median survival, 18.1 versus 10.5 months; P < 0.01 (chi2 test)].
Similar articles
- Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP. Akervall JA, et al. Cancer. 1997 Jan 15;79(2):380-9. Cancer. 1997. PMID: 9010112 - PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P, Fernández PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A. Jares P, et al. Cancer Res. 1994 Sep 1;54(17):4813-7. Cancer Res. 1994. PMID: 8062283 - Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.
Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Naitoh H, et al. Am J Pathol. 1995 May;146(5):1161-9. Am J Pathol. 1995. PMID: 7747810 Free PMC article. - [Analysis of the p16INK4, p15INK4B genes abnormality and the amplification of cyclin D1 gene in esophageal cancer].
Takamura H, Fushida S, Hashimoto T, Yagi M, Miyazaki I. Takamura H, et al. Nihon Rinsho. 1996 Apr;54(4):1043-8. Nihon Rinsho. 1996. PMID: 8920671 Review. Japanese. - The cyclin D1/PRAD1 oncogene in human neoplasia.
Arnold A. Arnold A. J Investig Med. 1995 Dec;43(6):543-9. J Investig Med. 1995. PMID: 8605613 Review. No abstract available.
Cited by
- PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in Pancreatic Cancer.
Chien TL, Wu YC, Lee HL, Sung WW, Yu CY, Chang YC, Lin CC, Wang CC, Tsai MC. Chien TL, et al. Medicina (Kaunas). 2023 Aug 24;59(9):1531. doi: 10.3390/medicina59091531. Medicina (Kaunas). 2023. PMID: 37763649 Free PMC article. - Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation.
Wang J, Su W, Zhang T, Zhang S, Lei H, Ma F, Shi M, Shi W, Xie X, Di C. Wang J, et al. Cell Death Dis. 2023 Apr 6;14(4):244. doi: 10.1038/s41419-023-05763-7. Cell Death Dis. 2023. PMID: 37024471 Free PMC article. Review. - Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance.
Mazumder S, Higgins PJ, Samarakoon R. Mazumder S, et al. Cancers (Basel). 2023 Feb 19;15(4):1316. doi: 10.3390/cancers15041316. Cancers (Basel). 2023. PMID: 36831657 Free PMC article. Review. - Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinoma.
Rudloff U. Rudloff U. Expert Opin Emerg Drugs. 2022 Sep;27(3):345-368. doi: 10.1080/14728214.2022.2134346. Epub 2022 Nov 3. Expert Opin Emerg Drugs. 2022. PMID: 36250721 Free PMC article. Review. - Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.
Zabihi M, Lotfi R, Yousefi AM, Bashash D. Zabihi M, et al. J Cancer Res Clin Oncol. 2023 Apr;149(4):1585-1606. doi: 10.1007/s00432-022-04135-6. Epub 2022 Jul 4. J Cancer Res Clin Oncol. 2023. PMID: 35781526 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials